I would like to know the status of Patent wo2013040557a2, specifically the itemized Example 4: Compassionate use of RNA-engineered CAR T cells.
- Was the patent issued?
- If so, who issued the patent and what documents do/did they review?
- As far as you know, was this treatment of Compassionate use of RNA-Engineered Car T-Cells used on a patient identified by the applying physicians to have pancreatic cancer? If so, what was the outcome of this trial and is a report available?